Literature DB >> 22116361

Controversies concerning the role of pendrin as an apical iodide transporter in thyroid follicular cells.

Aigerim Bizhanova1, Peter Kopp.   

Abstract

Pendred syndrome is an autosomal recessive disorder defined by sensorineural deafness, goiter and a partial organification defect of iodide. It is caused by biallelic mutations in the multifunctional anion transporter pendrin/SLC26A4. In human thyroid tissue, pendrin is localized at the apical membrane of thyroid follicular cells. The clinical phenotype of patients with Pendred syndrome and the fact that pendrin can mediate iodide efflux in transfected cells suggest that this anion exchanger may be involved in mediating iodide efflux into the follicular lumen, a key step in thyroid hormone biosynthesis. This concept has, however, been questioned. This review discusses supporting evidence as well as arguments questioning a role of pendrin in mediating iodide efflux in thyrocytes.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22116361     DOI: 10.1159/000335103

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  16 in total

1.  Atrophic thyroid follicles and inner ear defects reminiscent of cochlear hypothyroidism in Slc26a4-related deafness.

Authors:  Amiel A Dror; Danielle R Lenz; Shaked Shivatzki; Keren Cohen; Osnat Ashur-Fabian; Karen B Avraham
Journal:  Mamm Genome       Date:  2014-04-24       Impact factor: 2.957

Review 2.  Recent insights into the cell biology of thyroid angiofollicular units.

Authors:  Ides M Colin; Jean-François Denef; Benoit Lengelé; Marie-Christine Many; Anne-Catherine Gérard
Journal:  Endocr Rev       Date:  2013-01-24       Impact factor: 19.871

3.  The Effect of Tanespimycin (17-AAG) on Radioiodine Accumulation in Sodium-Iodide Symporter Expressing Cells.

Authors:  Kyoung Hyun Yu; Hyewon Youn; Myung Geun Song; Dong Soo Lee; June-Key Chung
Journal:  Nucl Med Mol Imaging       Date:  2012-08-15

Review 4.  Intrinsic regulation of thyroid function by thyroglobulin.

Authors:  Donald F Sellitti; Koichi Suzuki
Journal:  Thyroid       Date:  2014-01-17       Impact factor: 6.568

5.  Systematic quantification of the anion transport function of pendrin (SLC26A4) and its disease-associated variants.

Authors:  Koichiro Wasano; Satoe Takahashi; Samuel K Rosenberg; Takashi Kojima; Hideki Mutai; Tatsuo Matsunaga; Kaoru Ogawa; Kazuaki Homma
Journal:  Hum Mutat       Date:  2019-10-26       Impact factor: 4.878

6.  Transcriptomic signatures for ovulation in vertebrates.

Authors:  Dong Teng Liu; Michael S Brewer; Shixi Chen; Wanshu Hong; Yong Zhu
Journal:  Gen Comp Endocrinol       Date:  2017-01-19       Impact factor: 2.822

Review 7.  UPDATED UNDERSTANDING OF THE MOLECULAR TARGETS OF RADIOIODINE IN DIFFERENTIATED THYROID CANCER.

Authors:  Y Zhang; W Zou; X Zhu; L Jiang; C Gui; Q Fan; Y Tu; J Chen
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

Review 8.  Adverse perinatal conditions and the developmental origins of thyroid dysfunction-Lessons from Animal Models.

Authors:  Rosiane Aparecida Miranda; Egberto Gaspar de Moura; Patrícia Cristina Lisboa
Journal:  Endocrine       Date:  2022-08-29       Impact factor: 3.925

9.  Homozygous loss-of-function mutations in SLC26A7 cause goitrous congenital hypothyroidism.

Authors:  Hakan Cangul; Xiao-Hui Liao; Erik Schoenmakers; Jukka Kero; Sharon Barone; Panudda Srichomkwun; Hideyuki Iwayama; Eva G Serra; Halil Saglam; Erdal Eren; Omer Tarim; Adeline K Nicholas; Ilona Zvetkova; Carl A Anderson; Fiona E Karet Frankl; Kristien Boelaert; Marja Ojaniemi; Jarmo Jääskeläinen; Konrad Patyra; Christoffer Löf; E Dillwyn Williams; Manoocher Soleimani; Timothy Barrett; Eamonn R Maher; V Krishna Chatterjee; Samuel Refetoff; Nadia Schoenmakers
Journal:  JCI Insight       Date:  2018-10-18

10.  Diphenyleneiodonium, an inhibitor of NOXes and DUOXes, is also an iodide-specific transporter.

Authors:  C Massart; N Giusti; R Beauwens; J E Dumont; F Miot; J Van Sande
Journal:  FEBS Open Bio       Date:  2013-12-07       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.